Drugs / Avocado-soybean unsaponifiables
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07801742 Comparator | Aug 2025 → Jun 2026 | — | Sanatorio Allende | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Avocado-soybean unsaponifiables | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07801742 ↗ |
| Known as | Prontal | “Avocado-soybean unsaponifiables (Prontal) 300 mg were administered orally once nightly for 14 consecutive nights following total knee arthroplasty.” NCT07801742 ↗ |
| Route | Oral | “Avocado-soybean unsaponifiables (Prontal) 300 mg were administered orally once nightly for 14 consecutive nights following total knee arthroplasty.” NCT07801742 ↗ |